Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in several processes, including innate immune response; negative regulation of NF-kappaB transcription factor activity; and negative regulation of type I interferon-mediated signaling pathway. Localizes to cytosol and nucleus. Is expressed in liver. Orthologous to human NLRC5 (NLR family CARD domain containing 5).